Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae.
about
Correlation of serotypes and genotypes of macrolide-resistant Streptococcus agalactiae.Multicenter study of the mechanisms of resistance and clonal relationships of Streptococcus agalactiae isolates resistant to macrolides, lincosamides, and ketolides in Spain.New lnu(C) gene conferring resistance to lincomycin by nucleotidylation in Streptococcus agalactiae UCN36Erythromycin resistance and genetic elements carrying macrolide efflux genes in Streptococcus agalactiaePhenotypic and genotypic characterization of group B streptococcal isolates in southern Brazil.In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistanceDNA microarray-based typing of Streptococcus agalactiae isolates.Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.Serotypes, antibiotic susceptibilities, and multi-locus sequence type profiles of Streptococcus agalactiae isolates circulating in Beijing, China.Telithromycin susceptibility and genomic diversity of macrolide-resistant serotype III group B streptococci isolated in perinatal infections.Serotypes and genotypes of erythromycin-resistant group B streptococci in Korea.Molecular epidemiology and distribution of serotypes, genotypes, and antibiotic resistance genes of Streptococcus agalactiae clinical isolates from Guelma, Algeria and Marseille, France.Dominance of serotype Ia among group B Streptococci causing invasive infections in nonpregnant adults in PortugalPrevalence of vancomycin-resistant enterococcus in prenatal screening cultures.Epidemiology of Invasive Group B Streptococcal Disease in Alberta, Canada, from 2003 to 2013Phenotypic and genotypic characterization of Streptococcus agalactiae in pregnant women. First study in a province of ArgentinaRisk factors associated with group B streptococcus resistant to clindamycin and erythromycin in pregnant korean women.Antibiotic susceptibility in neonatal invasive isolates of Streptococcus agalactiae in a 2-year nationwide surveillance study in Germany.The genetic diversity and phenotypic characterisation of Streptococcus agalactiae isolates from Rio de Janeiro, Brazil.Prospective analysis of risk factors associated with group B streptococcal colonisation in neonates born at a tertiary care centre in India.Streptococcus agalactiae from pregnant women: antibiotic and heavy-metal resistance mechanisms and molecular typing.Investigation of serotype distribution and resistance genes profile in group B Streptococcus isolated from pregnant women: a Chinese multicenter cohort study.Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results.Macrolide resistance gene erm(TR) and erm(TR)-carrying genetic elements in Streptococcus agalactiae: characterization of ICESagTR7, a new composite element containing IMESp2907.Time-kill activity of the streptogramin NXL 103 against Gram-positive and -negative bacteria.ICESag37, a Novel Integrative and Conjugative Element Carrying Antimicrobial Resistance Genes and Potential Virulence Factors in Streptococcus agalactiae.Antimicrobial susceptibility of group B streptococci collected in two Belgian hospitals.A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand.In vitro activity of telithromycin against mefA and ermB erythromycin-resistant viridans streptococci isolated from bacteremia of oral origin in Spain.The draft genomes and investigation of serotype distribution, antimicrobial resistance of group B Streptococcus strains isolated from urine in Suzhou, China.
P2860
Q33628225-E47660D9-9611-4176-88E3-DA53BD034210Q33836754-953DD2F3-371E-4112-BDAE-66DAD5B2574AQ33883629-92C3173C-1B1D-46D6-862A-4A733B010ACBQ34228397-572D0E1B-FD32-4EF4-B40A-5686E4FA3B10Q34433251-B8B2DF53-98CA-4622-89FF-E1D0F4A4936CQ35007097-6E6B31FA-83B0-4E32-9CB3-F1A829C93C82Q35036001-84632A45-DDCC-4908-A0FE-D45E68D4FDF6Q35125919-C075064B-D959-48F3-B090-8454C5D573B9Q35188390-01D77F8F-F4F2-468C-AFE8-8656B604958BQ35547508-39148445-9C8C-4CB1-835D-942F5D5F8395Q35712918-964E5A5F-DB55-4E3F-8ED3-DA6E01834570Q35790825-A21254C5-0C74-49C6-901D-75F6F56F6334Q35867803-F03AC235-0076-4AEC-A82B-30E524E57757Q36242403-53538629-05F3-4B74-B546-68CB2A6E185FQ37040500-787A3CE2-E616-4E0E-9027-C722E360B28EQ37244560-0E331362-FFCE-4341-9215-D060EA20AE94Q37359339-CBAB4DF5-84EB-4961-BC8F-08FDD0078500Q37598608-66FA37B3-B7CF-4584-8493-C319D77470A2Q39664918-EA734783-8530-49DE-8A46-C20D47CCA96BQ40214664-6E243FEA-203F-4749-8189-E2A151966A1FQ40585275-500D478C-41C8-4B6D-B99A-2A43F43D4733Q40601705-2A92CBDA-6486-48D9-BA18-1A0DF8169B29Q40625576-6A097ACE-4F5B-4114-B37C-62FF87DB7051Q40867197-92430FC2-84E9-444F-B721-4C9BEF09176CQ41831210-26024146-101C-49AB-800E-79E086F23047Q42373421-657340AF-C202-4561-B5E9-305FF47970FFQ44915009-E2C23FD2-C21D-40A1-9863-CA41DB61A579Q45146794-C62DD5EE-CDA1-4C64-90F4-24FEDCD80491Q45197075-C0053C0A-905C-43D4-B9F1-D0D58B06B934Q55451100-2D1C1462-5A88-46D2-8574-5E948B0D6E9F
P2860
Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Erythromycin and clindamycin r ...... y in Streptococcus agalactiae.
@ast
Erythromycin and clindamycin r ...... y in Streptococcus agalactiae.
@en
Erythromycin and clindamycin r ...... y in Streptococcus agalactiae.
@nl
type
label
Erythromycin and clindamycin r ...... y in Streptococcus agalactiae.
@ast
Erythromycin and clindamycin r ...... y in Streptococcus agalactiae.
@en
Erythromycin and clindamycin r ...... y in Streptococcus agalactiae.
@nl
prefLabel
Erythromycin and clindamycin r ...... y in Streptococcus agalactiae.
@ast
Erythromycin and clindamycin r ...... y in Streptococcus agalactiae.
@en
Erythromycin and clindamycin r ...... y in Streptococcus agalactiae.
@nl
P2093
P2860
P1476
Erythromycin and clindamycin r ...... y in Streptococcus agalactiae.
@en
P2093
B A Sánchez
E Culebras
I Rodríguez-Avial
J J Picazo
M C Agreda
P2860
P304
P356
10.1128/AAC.47.3.1112-1114.2003
P407
P577
2003-03-01T00:00:00Z